Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus
- PMID: 15657875
- PMCID: PMC1196404
- DOI: 10.1086/428480
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus
Abstract
Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease caused by both genetic and environmental factors. Genome scans in families with SLE point to multiple potential chromosomal regions that harbor SLE susceptibility genes, and association studies in different populations have suggested several susceptibility alleles for SLE. Increased production of type I interferon (IFN) and expression of IFN-inducible genes is commonly observed in SLE and may be pivotal in the molecular pathogenesis of the disease. We analyzed 44 single-nucleotide polymorphisms (SNPs) in 13 genes from the type I IFN pathway in 679 Swedish, Finnish, and Icelandic patients with SLE, in 798 unaffected family members, and in 438 unrelated control individuals for joint linkage and association with SLE. In two of the genes--the tyrosine kinase 2 (TYK2) and IFN regulatory factor 5 (IRF5) genes--we identified SNPs that displayed strong signals in joint analysis of linkage and association (unadjusted P<10(-7)) with SLE. TYK2 binds to the type I IFN receptor complex and IRF5 is a regulator of type I IFN gene expression. Thus, our results support a disease mechanism in SLE that involves key components of the type I IFN system.
Figures


Similar articles
-
Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.Inflamm Res. 2015 Oct;64(10):817-24. doi: 10.1007/s00011-015-0865-2. Epub 2015 Aug 21. Inflamm Res. 2015. PMID: 26294277
-
Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.J Rheumatol. 2009 Aug;36(8):1631-8. doi: 10.3899/jrheum.081160. Epub 2009 Jun 30. J Rheumatol. 2009. PMID: 19567624
-
Catalytically Impaired TYK2 Variants are Protective Against Childhood- and Adult-Onset Systemic Lupus Erythematosus in Mexicans.Sci Rep. 2019 Aug 21;9(1):12165. doi: 10.1038/s41598-019-48451-3. Sci Rep. 2019. PMID: 31434951 Free PMC article.
-
Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.Clin Rheumatol. 2024 Aug;43(8):2403-2416. doi: 10.1007/s10067-024-07046-8. Epub 2024 Jul 4. Clin Rheumatol. 2024. PMID: 38963465 Review.
-
Polymorphisms in STK17A gene are associated with systemic lupus erythematosus and its clinical manifestations.Gene. 2013 Sep 25;527(2):435-9. doi: 10.1016/j.gene.2013.06.074. Epub 2013 Jul 13. Gene. 2013. PMID: 23860322 Review.
Cited by
-
TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits.PLoS One. 2015 Apr 7;10(4):e0122271. doi: 10.1371/journal.pone.0122271. eCollection 2015. PLoS One. 2015. PMID: 25849893 Free PMC article.
-
Host genetic variation influences gene expression response to rhinovirus infection.PLoS Genet. 2015 Apr 13;11(4):e1005111. doi: 10.1371/journal.pgen.1005111. eCollection 2015 Apr. PLoS Genet. 2015. PMID: 25874939 Free PMC article.
-
The COP9 signalosome interacts with and regulates interferon regulatory factor 5 protein stability.Mol Cell Biol. 2013 Mar;33(6):1124-38. doi: 10.1128/MCB.00802-12. Epub 2012 Dec 28. Mol Cell Biol. 2013. Retraction in: Mol Cell Biol. 2017 Nov 28;37(24):e00477-17. doi: 10.1128/MCB.00477-17. PMID: 23275442 Free PMC article. Retracted.
-
Pathogenesis and Treatment of T-Large Granular Lymphocytic Leukemia (T-LGLL) in the Setting of Rheumatic Disease.Front Oncol. 2022 Jun 7;12:854499. doi: 10.3389/fonc.2022.854499. eCollection 2022. Front Oncol. 2022. PMID: 35747794 Free PMC article. Review.
-
Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations.Curr Genomics. 2014 Feb;15(1):52-65. doi: 10.2174/138920291501140306113715. Curr Genomics. 2014. PMID: 24653663 Free PMC article.
References
Electronic-Database Information
-
- CHIP Bioinformatics Tools, http://snpper.chip.org/bio/top (for SNPer)
-
- dbSNP Home Page, http://www.ncbi.nlm.nih.gov/SNP/
-
- Haploview, http://www.broad.mit.edu/mpg/haploview/
-
- Jost Web site, http://www.loujost.com/
-
- Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for SLE) - PubMed
References
-
- Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511 - PubMed
-
- Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, Shark KB, Grande WJ, Hughes KM, Kapur V, Gregersen PK, Behrens TW (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci USA 100:2610–2615 - PMC - PubMed
-
- Barnes B, Lubyova B, Pitha PM (2002) On the role of IRF in host defense. J Interferon Cytokine Res 22:59–71 - PubMed
-
- Barnes BJ, Kellum MJ, Pinder KE, Frisancho JA, Pitha PM (2003) Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res 63:6424–6431 - PubMed
-
- Barnes BJ, Moore PA, Pitha PM (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon α genes. J Biol Chem 276:23382–23390 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases